Company

Prelude Therapeutics

Biotechnology Research Wilmington, De, United States 135 employees

Employees: 135
Contacts: 3
Emails: 3
Phones: 2

www.preludetx.com LinkedIn

Prelude Therapeutics Overview

Headquarters: Wilmington, De, United States
Website: www.preludetx.com
Industry: Biotechnology Research
Employees: 135
Founded: 2016
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Oncology Cancer therapeutics Precision medicines Biotech Precision oncology Cancer Research small molecule therapies cancer biology

About Prelude Therapeutics

Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell pathways. The Company’s diverse pipeline is comprised of highly differentiated, potentially best-in-class proprietary small molecule compounds aimed at addressing clinically validated pathways for cancers with selectable underserved patients. Prelude’s pipeline includes three candidates currently in clinical development: PRT3789 an IV administered, potent and highly selective SMARCA2 degrader, PRT2527, a potent and highly selective CDK9 inhibitor, PRT3645 a next generation CDK4/6 inhibitor, and a preclinical oral candidate targeting SMARCA2.

Prelude Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

Prelude Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Erin Hugger Difilippo	Vice President of Business Development		View
Aimee Crombie	Senior Vice President and Head	Collegeville, Pennsylvania, United States	Email Phone
William Sun	Vice President at Prelude Therapeutics	Downingtown, Pennsylvania, United States	Email Phone
Chris Tankersley	Executive Director, Clinical Science @	Longmont, Colorado, United States	Email